Skip to main content
Premium Trial:

Request an Annual Quote

Qiagen, Jurilab


Qiagen last week rolled out its Array-Ready oligonucleotide set for the Xenopus tropicalis genome. The new set of oligos contains approximately 11,000 70-mer probes representing Xenopus transcripts from sequence and cluster data provided by Jim Smith of the Wellcome Trust/Cancer Research UK Gurdon Institute of Cancer and Developmental Biology in Cambridge, UK, which also beta tested the product. Each probe is melting-temperature normalized and includes a 5; amino linker for substrate attachment in microarray manufacturing. Annotation for the oligo set will be prov-ided on the Qiagen oligo microarray database. The product is provided in a 384-well plate format with 600 picomoles of probe per well. The set also includes a control plate with 24 controls (12 positive and 12 negative) in 16 replicates. Sample sets, which contain 96 optimized 70-mer probes in a 384-well format at 600 picomoles per well are also available, the company said. Pricing was not disclosed.

Finland’s Jurilab last week launched DrugMEt, a microarray-based genotyping test for the identification of genetically-mediated metabolic patterns in clinical trials. The test contains 27 SNPs from eight different enzymes and is designed to be used to genotype those thought to play a role in the metabolic pathways of many drugs. The product comes bundled with the company’s SnpRater software. Pricing was not disclosed.

The Scan

WHO Seeks Booster Pause

According to CNN, the World Health Organization is calling for a moratorium on administering SARS-CoV-2 vaccine boosters until more of the world has received initial doses.

For Those Long Legs

With its genome sequence and subsequent RNAi analyses, researchers have examined the genes that give long legs to daddy longlegs, New Scientist says.

September Plans

The New York Times reports that the US Food and Drug Administration is aiming for early September for full approval of the Pfizer-BioNTech SARS-CoV-2 vaccine.

Nucleic Acids Research Papers on Targeting DNA Damage Response, TSMiner, VarSAn

In Nucleic Acids Research this week: genetic changes affecting DNA damage response inhibitor response, "time-series miner" approach, and more.